Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality ORIGINAL INVESTIGATION Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality Yadong Cui, MD, PhD; Roger S. Blumenthal, MD; Jodi A. Flaws, PhD; Maura K. Whiteman, BS; Patricia Langenberg, PhD; Paul S. Bachorik, PhD; Trudy L. Bush, PhD, MHS† Background: Non–high-density lipoprotein choles- Results: A total of 234 CVD deaths in men and 113 CVD terol (non–HDL-C) contains all known and potential ath- deaths in women occurred during follow-up. Levels of erogenic lipid particles. Therefore, non–HDL-C level may HDL-C and non–HDL-C at baseline were significant and be as good a potential predictor of risk for cardiovascu- strong predictors of CVD death in both sexes. In con- lar disease (CVD) as low-density lipoprotein choles- trast, LDL-C level was a somewhat weaker predictor of terol (LDL-C). CVD death in both. Differences of 0.78 mmol/L (30 mg/ dL) in non–HDL-C and LDL-C levels corresponded to Objectives: To determine whether non–HDL-C level could increases in CVD risk of 19% and 15%, respectively, in be useful in predicting CVD mortality and to compare the men. In women, differences of 0.78 mmol/L (30 mg/dL) predictive value of non–HDL-C and LDL-C levels. in non–HDL-C and LDL-C levels corresponded to in- creases in CVD risk http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality

Loading next page...
 
/lp/american-medical-association/non-high-density-lipoprotein-cholesterol-level-as-a-predictor-of-Ec3Fn0MlEl

References (58)

Publisher
American Medical Association
Copyright
Copyright 2001 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/archinte.161.11.1413
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL INVESTIGATION Non–High-Density Lipoprotein Cholesterol Level as a Predictor of Cardiovascular Disease Mortality Yadong Cui, MD, PhD; Roger S. Blumenthal, MD; Jodi A. Flaws, PhD; Maura K. Whiteman, BS; Patricia Langenberg, PhD; Paul S. Bachorik, PhD; Trudy L. Bush, PhD, MHS† Background: Non–high-density lipoprotein choles- Results: A total of 234 CVD deaths in men and 113 CVD terol (non–HDL-C) contains all known and potential ath- deaths in women occurred during follow-up. Levels of erogenic lipid particles. Therefore, non–HDL-C level may HDL-C and non–HDL-C at baseline were significant and be as good a potential predictor of risk for cardiovascu- strong predictors of CVD death in both sexes. In con- lar disease (CVD) as low-density lipoprotein choles- trast, LDL-C level was a somewhat weaker predictor of terol (LDL-C). CVD death in both. Differences of 0.78 mmol/L (30 mg/ dL) in non–HDL-C and LDL-C levels corresponded to Objectives: To determine whether non–HDL-C level could increases in CVD risk of 19% and 15%, respectively, in be useful in predicting CVD mortality and to compare the men. In women, differences of 0.78 mmol/L (30 mg/dL) predictive value of non–HDL-C and LDL-C levels. in non–HDL-C and LDL-C levels corresponded to in- creases in CVD risk

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jun 11, 2001

There are no references for this article.